BN Business News
Add your company to Business Communicator →

Regulacje i polityka gospodarcza · 15/09/2021

Wyeth Pharmaceuticals, LLC Receives Authorization for mRNA Bulk Drug Substance Production in Foreign-Trade Zone 27-Boston, Massachusetts

Wyeth Pharmaceuticals, LLC has been authorized to produce mRNA bulk drug substance in Foreign-Trade Zone 27-Boston, Massachusetts, as part of a proposed production activity.

Source: Federal Register — All DocumentsOpen original release →